Simulations are not the major bottleneck in drug development. More generally, the naysayers in this case are likely to be people who actually have some knowled

Simulations are not the major bottleneck in drug development. More generally, the naysayers in this case are likely to be people who actually have some knowledge of drug development, and have seen countless companies that promised to revolutionize drug discovery by using computers, most of which are no longer in existence. If an AI-powered company can suddenly start passing Phase III clinical trials at an unprecedented rate, then I'll be genuinely impressed.